Mitochondrial Apoptosis and Muscle Atrophy in Ovarian Cancer
2026-07-03
This study demonstrates that mitochondrial ROS-driven apoptosis, but not necroptosis, is activated in type II B-rich skeletal muscle during ovarian cancer progression. However, pharmacological inhibition of mitochondrial ROS and caspase cascades does not prevent muscle atrophy, challenging assumptions about causality and guiding future research on muscle wasting mechanisms in cancer.
CCT007093: Applied PPM1D Inhibitor Workflows for AKI and Can
2026-07-02
CCT007093, a selective PPM1D inhibitor from APExBIO, enables researchers to dissect p38 MAPK signaling and cell fate decisions in both acute kidney injury and cancer models. This guide delivers evidence-based protocols, troubleshooting strategies, and comparative insights to maximize assay productivity and accuracy.
Integrated Protocols for mRNA Lipid Nanoparticle Evaluation
2026-07-02
Ma et al. provide a comprehensive, step-by-step protocol for the formulation, characterization, and evaluation of mRNA lipid nanoparticles (LNPs), lowering technical barriers for researchers developing mRNA-based therapeutics. Their unified workflow offers practical guidance for reproducibility and translational research.
Betaine Hydrochloride: Biochemical Roles and Research Integr
2026-07-01
Betaine hydrochloride is a high-purity, water-soluble quaternary ammonium salt pivotal in metabolic enzyme and protease research. Its unique solubility and molecular stability enable reproducible biochemical assays, while protocol adherence is essential for optimal results. APExBIO’s N1700 product specification and rigorous QC further enhance reliability.
Temporal Transcriptomics Uncovers Host-Targeted Anti-EBOV St
2026-07-01
This study applies integrated time-series transcriptomics to map how Ebola virus (EBOV) dynamically reprograms host cell gene expression. By combining network analysis and pharmacological screening, the authors identify infection-phase-specific host pathways and actionable targets, including Sorafenib, that inhibit EBOV replication—offering a framework for host-directed antiviral discovery.
Meropenem: β-Lactam Antibiotic Carbapenem in Infection Model
2026-06-30
Meropenem from APExBIO is a gold-standard β-lactam antibiotic carbapenem for translational research on Gram-negative and Gram-positive infections. This guide delivers advanced experimental workflows, optimization strategies, and troubleshooting tips to harness its full potential in resistance and septicemia modeling.
Trametinib (GSK1120212): Decoding Tumor Heterogeneity in MEK
2026-06-30
Explore how Trametinib (GSK1120212) enables advanced analysis of therapeutic heterogeneity in cancer, with a focus on MEK-ERK pathway modulation. This article uniquely connects product insights with translational research for assay optimization.
Cy5 TSA Fluorescence System Kit: HRP-Catalyzed Signal Amplif
2026-06-29
The Cy5 TSA Fluorescence System Kit utilizes horseradish peroxidase catalyzed tyramide deposition to achieve up to 100-fold fluorescence signal amplification. This enables highly sensitive detection of low-abundance targets in immunohistochemistry, immunocytochemistry, and in situ hybridization. The kit maintains high specificity and is validated for robust performance across diverse molecular biology workflows.
MK-2206 dihydrochloride: Rewiring PI3K/Akt Signaling for Tra
2026-06-29
This thought-leadership article explores how MK-2206 dihydrochloride, a nanomolar-potency allosteric Akt inhibitor from APExBIO, empowers translational researchers to dissect and modulate the PI3K/Akt/mTOR pathway in disease-relevant models. Integrating mechanistic insights from recent host-pathogen research, scenario-driven workflow guidance, and competitive landscape analysis, it provides actionable strategies for advancing cancer, immunology, and endometriosis research, while highlighting both the promise and boundaries of this targeted approach.
Ferrostatin-1 (Fer-1): Advancing Ferroptosis Assays via Mech
2026-06-28
Explore how Ferrostatin-1 (Fer-1) uniquely enables mechanistic dissection of ferroptosis and oxidative lipid damage inhibition in advanced cellular models. This article offers deeper insight into practical assay design and translational research beyond standard workflows.
FPH1 (BRD-6125) Accelerates Human Hepatocyte Proliferation
2026-06-27
FPH1 (BRD-6125) empowers researchers to expand functional primary human hepatocytes with unprecedented donor-independence and reproducibility. Its synergy with advanced gene regulation and optogenetic workflows uniquely positions it for next-generation regenerative and translational applications.
Sulfur Transport Regulates Soybean Nodule Senescence via RNS
2026-06-26
This study demonstrates that sulfur supply to the symbiosome delays nodule senescence in soybean by maintaining glutathione levels and enhancing reactive nitrogen species (RNS) scavenging. These findings identify sulfur transport as a pivotal regulatory step for sustaining symbiotic nitrogen fixation and offer new targets for improving legume productivity.
SCH772984 ERK1/2 Inhibitor: Applied Workflows & Troubleshoot
2026-06-26
SCH772984 enables precise, nanomolar-level ERK1/2 inhibition for dissecting MAPK/ERK signaling, even in challenging BRAF, NRAS, and KRAS mutant tumor models. This guide delivers protocol refinements, troubleshooting strategies, and reference-driven insights to maximize experimental robustness—especially where radioresistance and pathway crosstalk complicate cancer research.
Telmisartan in Cardiac Hypertrophy Research: Protocols & Inn
2026-06-25
Telmisartan empowers researchers to dissect angiotensin II signaling and cardiac hypertrophy with precision, thanks to its potent AT1 receptor antagonism. This guide delivers actionable protocols, troubleshooting insights, and highlights the integration of Telmisartan with emerging necroptosis pathway studies for next-generation cardiovascular disease research.
LG 101506 (RXR Modulator): Precision Tools for Decoding Immu
2026-06-25
Explore how LG 101506, a powerful RXR modulator, advances research in nuclear receptor signaling and immune evasion. This article delivers new insights into assay design and translational cancer studies.
458 records 13/31 page Previous Next First page 上5页 1112131415 下5页 Last page